GC
G Bradley Cole (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $299K of KNSA (3,673 sh × $81.43, as filed), executed Jul 29. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$434K
shares × price, as filed
Last traded
Jul 29
Filed Jul 31
Median ADV $36.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $434K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CSTLRecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$299K3,673 sh × $81.43
Exec Jul 29
Filed Jul 31 · 4:34 PM ET CSTLSALE Castle Biosciences, Inc. View filing → $135K
4,748 sh × $28.44
Exec Mar 5
Filed Mar 9 · 5:30 PM ET